Search

everythinglearnresearchcommunity

for

Search:↓

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

High DKK1 levels predict worse survival in head and neck cancer.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

miR-200c-3p could help diagnose and treat alopecia areata.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

β1 integrin is essential for the survival, growth, and movement of human epithelial progenitor cells.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Interleukin-1 increases keratin K6 production in skin cells.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

CCL 27 levels are similar in people with and without alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.